Flanagan JL, Simmons PA, Vehige J, Willcox M, Garrett Q
15-24% at diabetes doses), vomiting, diarrhea, constipation, and abdominal discomfort, which may be difficult to distinguish from neurogenic bowel dysfunction in MS patients [11] [3] Fatigue : Reported in clinical trials and potentially additive to MS-related fatigue, one of the most disabling MS symptoms Dizziness : May occur due to blood pressure changes or dehydration, overlapping with MS-related balance and vestibular symptoms Weight loss induced by tirzepatidewhile therapeutically beneficial for metabolic healthrequires monitoring in MS patients, as unintentional or excessive weight loss could affect mobility, muscle strength, and overall functional status
Accountability Coaching Addresses healthy habits and the psychological relationship to food to ensure success, maximize results, and offer transformation and breakthroughs
Clin Chem 2000